title: Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.
authors.forename: E
authors.initials: E
authors.lastname: Schober
authors.forename: E
authors.initials: E
authors.lastname: Schoenle
authors.forename: J
authors.initials: J
authors.lastname: Van Dyk
authors.forename: K
authors.initials: K
authors.lastname: Wernicke-Panten
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000453:epidemiology / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000069036:Insulin Glargine; D007336:Insulin, Isophane / Q000009:adverse effects / Q000627:therapeutic use*; D049528:Insulin, Long-Acting
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine; D007336:Insulin, Isophane